Liraglutide for diabetes and obesity: what the evidence says

What did @dr.leytonmd actually say?

Honestly, not much that we can verify. The transcript captured here is largely incoherent, a string of repeated phrases and fragmented Spanish that does not produce a clear medical claim. The caption promises an explanation of what liraglutide is used for, covering diabetes and obesity, but the spoken content doesn't deliver a coherent argument we can pin down and check.

What we can do is fact-check the implied premise of the video: that liraglutide is a useful tool for type 2 diabetes and obesity management. That claim, at least, is well-grounded in the medical literature, and it's worth unpacking what the evidence actually says versus what tends to circulate on health TikTok about GLP-1 receptor agonists as a category.

Does the science back this up?

Yes, the core premise holds. Liraglutide has two FDA-approved indications with solid trial data behind both of them. The short version: it works for blood sugar control in type 2 diabetes, and it produces meaningful weight loss in people with obesity, though it has largely been overshadowed by newer agents.

The LEADER trial (Marso et al., 2016, New England Journal of Medicine) followed over 9,000 patients with type 2 diabetes and established cardiovascular risk. Liraglutide reduced major adverse cardiovascular events by 13% compared to placebo over a median of 3.8 years. That was a significant result and helped cement GLP-1 agonists as a class with benefits beyond glucose control.

For weight loss, the SCALE Obesity and Prediabetes trial (Pi-Sunyer et al., 2015, NEJM) showed that liraglutide 3.0 mg daily, marketed as Saxenda, produced an average weight loss of about 8% of body weight over 56 weeks, compared to roughly 2.6% with placebo. Meaningful, but modest compared to what semaglutide trials have since shown.

What did they get wrong (or right)?

We can't fairly accuse @dr.leytonmd of getting specific facts wrong when the transcript doesn't contain specific facts. The video caption correctly identifies the two main clinical use cases, diabetes and obesity, which is accurate framing. No credit for nuance here, but no penalty for misinformation either, at least not from what we can evaluate.

What the video seems to miss by omission, based on the hashtags and category alone, is any mention of where liraglutide sits today relative to semaglutide and tirzepatide. Liraglutide is a daily injection. Semaglutide is once weekly and outperforms it on weight loss endpoints. The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide 2.4 mg produced roughly 14.9% average weight loss versus the 8% range seen with liraglutide. That context matters when someone watches a TikTok about liraglutide and wonders whether it's the right option for them.

What should you actually know?

Liraglutide is a legitimate, well-studied medication with two distinct FDA-approved forms: Victoza for type 2 diabetes management and Saxenda for chronic weight management. They are the same molecule at different doses, and that distinction matters clinically.

It works by mimicking GLP-1, a hormone released after eating. That mechanism slows gastric emptying, reduces appetite signaling in the brain, and stimulates insulin release in a glucose-dependent way, meaning it doesn't cause hypoglycemia on its own the way older diabetes drugs can.

• Liraglutide is not a cure for diabetes or obesity. It manages these conditions while in use.
• Common side effects include nausea, vomiting, and diarrhea, particularly early in treatment.
• The FDA label carries a boxed warning about thyroid C-cell tumors observed in rodent studies. The clinical relevance in humans remains under study, but patients with a personal or family history of medullary thyroid carcinoma should not use it.
• Compounded liraglutide is not the same as FDA-approved Victoza or Saxenda. Potency, sterility, and formulation are not guaranteed in compounded versions.

If you're deciding between GLP-1 options, that conversation belongs with a licensed prescriber who knows your full medical history, not a TikTok comment section.